0221 Impact of GLP-1 receptor agonists on the risk of inflammatory arthropathies in patients with hidradenitis suppurativa: A population-based cohort study
Journal of Investigative Dermatology · 2026-08 · 146 (8) · S39
DOI: 10.1016/j.jid.2026.06.252 ↗Kurz gefasst
Kohortenstudie in der Zeitschrift Journal of Investigative Dermatology, 2026-08. Verfasst von A. Ure und 7 weiteren Autor:innen.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Zitieren
APA
Ure, A., Aflatooni, S., Cortes, J., Smart, K., Palma, G., Johnsen, N., Nong, Y., & Armstrong, A. (2026). 0221 Impact of GLP-1 receptor agonists on the risk of inflammatory arthropathies in patients with hidradenitis suppurativa: A population-based cohort study. Journal of Investigative Dermatology, 146(8), S39. https://doi.org/10.1016/j.jid.2026.06.252
Vancouver
Ure A, Aflatooni S, Cortes J, Smart K, Palma G, Johnsen N, et al. 0221 Impact of GLP-1 receptor agonists on the risk of inflammatory arthropathies in patients with hidradenitis suppurativa: A population-based cohort study. Journal of Investigative Dermatology. 2026;146(8):S39. doi:10.1016/j.jid.2026.06.252
BibTeX
@article{Ure2026,
author = {Ure, A. and Aflatooni, S. and Cortes, J.A. and Smart, K. and Palma, G. and Johnsen, N.A. and Nong, Y. and Armstrong, A.W.},
title = {0221 Impact of GLP-1 receptor agonists on the risk of inflammatory arthropathies in patients with hidradenitis suppurativa: A population-based cohort study},
journal = {Journal of Investigative Dermatology},
year = {2026},
volume = {146},
number = {8},
pages = {S39},
doi = {10.1016/j.jid.2026.06.252}
}
EUVIMED